Literature DB >> 2321577

Ovarian carcinomas with transitional cell carcinoma pattern.

E G Silva1, S S Robey-Cafferty, T L Smith, D M Gershenson.   

Abstract

The authors report 88 cases of ovarian carcinoma containing areas of transitional cell carcinoma (TCC). The tumors were found in women 28-76 years old (mean, 51 years). Fifteen patients presented with stage II, 59 with stage III, and 14 with stage IV disease. Ten neoplasms were composed of only TCC, 48 were predominantly TCC, and 30 had foci of TCC but the predominant component was serous, endometrioid, undifferentiated, or unclassified adenocarcinoma. After the primary resection of the neoplasm, 76 patients received chemotherapy, 4 received chemotherapy and radiotherapy, and 5 received radiotherapy only; 2 refused further treatment and 1 patient died immediately after the first operation. Estimated five-year survival rates were 37% for the entire group and 41% for those who received chemotherapy. Favorable prognostic indicators, statistically significant, were low clinical stage, predominant TCC in the primary tumor, and a negative second-look operation. Other prognostic indicators were the amount of residual tumor after the first operation and tumor differentiation. When the primary neoplasm was predominantly TCC, another prognostic indicator was the type of carcinoma present in the metastases. Five-year follow-up shows that 56% of the patients whose metastases were predominantly TCC have no evidence of disease, whereas only 7% of the patients whose metastases are predominantly non-TCC are disease-free. The authors' study indicates that ovarian carcinomas containing predominant TCC pattern have an excellent response to different chemotherapy regimens. Tumor recurrences and lack of response to chemotherapy are often associated with a change in the histologic appearance of the metastatic lesion.

Entities:  

Mesh:

Year:  1990        PMID: 2321577     DOI: 10.1093/ajcp/93.4.457

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  14 in total

1.  Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.

Authors:  Rajesh Singh; Cecil R Stockard; William E Grizzle; James W Lillard; Shailesh Singh
Journal:  Int J Oncol       Date:  2011-05-31       Impact factor: 5.650

Review 2.  Transitional cell carcinoma of the ovary: a rare case and review of literature.

Authors:  E M Tazi; I Lalya; M F Tazi; Y Ahellal; H M'rabti; H Errihani
Journal:  World J Surg Oncol       Date:  2010-11-14       Impact factor: 2.754

3.  Good survival in a patient with recurrent transitional cell carcinoma of the ovary: A case report of PET-CT for detection and follow-up.

Authors:  Jingquan Ma; Lijuan Yu; Xinghua Wang; G E Lou
Journal:  Oncol Lett       Date:  2015-05-20       Impact factor: 2.967

4.  Proteomic analysis of transitional cell carcinoma-like variant of tubo-ovarian high-grade serous carcinoma.

Authors:  Basile Tessier-Cloutier; Dawn R Cochrane; Anthony N Karnezis; Shane Colborne; Jamie Magrill; Aline Talhouk; Jonathan Zhang; Samuel Leung; Christopher S Hughes; Anna Piskorz; Angela S Cheng; Kendall Greening; Andreas du Bois; Jacobus Pfisterer; Robert A Soslow; Stefan Kommoss; James D Brenton; Gregg B Morin; C Blake Gilks; David G Huntsman; Friedrich Kommoss
Journal:  Hum Pathol       Date:  2020-04-29       Impact factor: 3.466

5.  Transitional cell carcinoma of the ovary (Review).

Authors:  Satoshi Ichigo; Hiroshi Takagi; Kazutoshi Matsunami; Takayuki Murase; Tsuneko Ikeda; Atsushi Imai
Journal:  Oncol Lett       Date:  2011-10-21       Impact factor: 2.967

Review 6.  The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded.

Authors:  Robert J Kurman; Ie-Ming Shih
Journal:  Am J Pathol       Date:  2016-04       Impact factor: 4.307

7.  Invasion Patterns of Metastatic Extrauterine High-grade Serous Carcinoma With BRCA Germline Mutation and Correlation With Clinical Outcomes.

Authors:  Yaser R Hussein; Jennifer A Ducie; Angela G Arnold; Noah D Kauff; Hebert A Vargas-Alvarez; Evis Sala; Douglas A Levine; Robert A Soslow
Journal:  Am J Surg Pathol       Date:  2016-03       Impact factor: 6.394

8.  [Transitional cell carcinoma of the ovary. Morphological and clinical features].

Authors:  F Kommoss; S Kommoss; J Eichhorn; D Schmidt
Journal:  Pathologe       Date:  2007-05       Impact factor: 1.011

9.  Bilateral malignant mixed serous adenocarcinoma and malignant transitional cell carcinoma of the ovaries: An extremely rare neoplasm.

Authors:  Ozhan Ozdemir; Mustafa Erkan Sari; Cemal Resat Atalay; Ertugrul Sen; Esra Ozhamam
Journal:  Interv Med Appl Sci       Date:  2015-09-28

10.  Transitional cell carcinoma of the ovary: case series and review of literature.

Authors:  Rajashree J Ingin; Sainath K Andola; Ashraf Ahmed Zubair
Journal:  J Clin Diagn Res       Date:  2014-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.